C07C 2603/32
Dibenzocycloheptenes
Official title: Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
C07C2603/32 (Dibenzocycloheptenes) appears on 124 US grants and 109 published applications in this corpus.
Search patents in C07C- Granted patents
- 124
- Published applications
- 109
- Assignees
- 90
- Inventors
- 433
- Latest grant
- 11 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 7 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 7 | 5 |
| 2002 | 6 | 16 |
| 2003 | 13 | 4 |
| 2004 | 7 | 10 |
| 2005 | 4 | 8 |
| 2006 | 6 | 10 |
| 2007 | 3 | 6 |
| 2008 | 4 | 4 |
| 2009 | 1 | 6 |
| 2010 | 1 | 2 |
| 2011 | 1 | 2 |
| 2012 | 2 | 2 |
| 2013 | 0 | 1 |
| 2014 | 4 | 1 |
| 2015 | 1 | 6 |
| 2016 | 0 | 3 |
| 2017 | 2 | 7 |
| 2018 | 1 | 3 |
| 2019 | 4 | 1 |
| 2020 | 2 | 0 |
| 2021 | 1 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 3 |
| 2024 | 1 | 2 |
| 2025 | 1 | 3 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Abietanes and methods of making and using the same11 Feb 2025US 12,221,419 B2The Florida State University Research Foundation, Inc.
- Polycyclic carbogenic molecules and uses thereof as anti-cancer agents21 May 2024US 11,987,546 B2Northwestern University
- Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials9 Aug 2022US 11,407,743 B2Centre National De La Recherche Scientifique
- Polycyclic carbogenic molecules and uses thereof as anti-cancer agents29 Mar 2022US 11,286,226 B2Northwestern University
- Polymerizable compound and optically anisotropic body16 Feb 2021US 10,919,870 B2DIC Corporation
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Sirtuin modulating compounds, including sirtuin activating compounds, and applications thereof23 Apr 2026US 2026/0109713 A1
- Compounds and methods for liquid phase synthesis12 Jun 2025US 2025/0188019 A1Eli Lilly and Company
- Abietanes and methods of making and using the same15 May 2025US 2025/0154106 A1The Florida State University Research Foundation, Inc.
- Anti-inflammatory and analgesic compounds and use thereof24 Apr 2025US 2025/0129012 A1Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Muscarinic receptor antagonists138US 6,693,202 B1Theravance, Inc. · 2004
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Anti-inflammatory compounds62US 6,509,369 B2Ortho-McNeil Pharmaceutical, Inc. · 2003
- Tricyclic aromatic compounds59US 4,871,865 ABurroughs Wellcome Co. · 1989
- Tricyclic aromatic compounds51US 4,923,892 ABurroughs Wellcome Co. · 1990